Phase I/II studies of combination chemotherapy with S-1 and platinum in patients with previously untreated metastatic or recurrent gastric cancer

Gastric Cancer

Volumn 12, Issue SUPPL. 1, 2009, Pages 38-42

  Kang, Yoon Koo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Chemotherapy; Gastric cancer; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PLATINUM;

ANEMIA; ANOREXIA; ASTHENIA; CANCER RECURRENCE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; GRANULOCYTOPENIA; HUMAN; INFECTION; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; STOMACH CANCER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 64949116987     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-008-0472-9     Document Type: Review

References (34)

1. M.D. Parkin F. Bray J. Ferlay P. Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108
2. J.Y. Lee H.Y. Kim K.H. Kim H.D. Jang J.B. Kim J.H. Lee 2003 No changing trends in incidence of gastric cardia cancer in Korea J Korean Med Sci 18 53 57
3. J.A. Ajani 2005 Evolving chemotherapy for advanced gastric cancer Oncologist 10 Suppl3 49 58
4. A.D. Wagner W. Grothe J. Haerting G. Klebr A. Grothey W.E. Fleig 2006 Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data J Clin Oncol 24 2903 2909
5. M. Scartozzi E. Galizia L. Verdecchia R. Berardi S. Antognoli S. Chiorrini 2007 Chemotherapy for advanced gastric cancer: across the years for a standard of care Expert Opin Pharmacother 8 797 808
6. A. Ohtsu 2005 Current status and future prospects of chemotherapy for metastatic gastric cancer: a review Gastric Cancer 8 95 102
7. Y. Maehara 2003 S-1 in gastric cancer: a comprehensive review Gastric Cancer 6 Suppl1 2 8
8. J.L. Lee H.J. Kang Y.K. Kang M.H. Ryu H.M. Chang T.W. Kim 2008 Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer Cancer Chemother Pharmacol 61 837 845
9. W. Koizumi M. Kurihara S. Nakano K. Hasegawa 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197
10. B. Nakata Y. Mitachi A. Tsuji S. Yamamitsu K. Hirata T. Shirasaka 2004 Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902) Clin Cancer Res 10 1664 1669
11. T. Taguchi Y. Inuyama R. Kanamaru K. Hasegawa S. Akazawa H. Niitani 1997 Phase I study of S-1 Jpn J Cancer Chemother 24 2253 2264
12. W. Koizumi S. Tanabe K. Saigenji A. Ohtsu N. Boku F. Nagashima 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212
13. Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassum) in advanced gastric cancer patients Eur J Cancer 34 715 720
14. H. Baba M. Yamamoto K. Endo Y. Ikeda Y. Toh S. Kohnoe 2003 Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer Gastric Cancer 6 Suppl1 45 49
15. S. Tsujitani K. Fukuda N. Kaibara 2003 Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer Gastric Cancer 6 Suppl1 50 57
16. Y. Sato H. Kondo K. Honda D. Takahari T. Sumiyoshi Y. Tsuji 2005 A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen Int J Clin Oncol 10 40 44
17. I. Hyodo T. Nishina T. Moriwaki S. Endo T. Terao K. Hirao 2003 A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting Eur J Cancer 39 2328 2333
18. Y. Kimura N. Kikkawa S. Iijima T. Kato Y. Naoi T. Hayashi 2003 A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice Gastric Cancer 6 Suppl1 34 39
19. F. Nagashima A. Ohtsu S. Yoshida K. Ito 2005 Japanese nationwide post-marketing survey of S-1 in patients with advanced gastric cancer Gastric Cancer 8 6 11
20. P. Chollet P. Schöffski K. Weigang-Köhler J.H. Schellens H. Cure N. Pavlidis 2003 Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer: a trial performed by the EORTC early clinical studies group (ECSG) Eur J Cancer 39 1264 1270
21. J.A. Ajani J. Faust K. Ikeda J.C. Yao H. Anbe K.L. Carr 2005 Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma J Clin Oncol 23 6957 6965
22. S.J. Cohen C.G. Leichman G. Yeslow M. Beard A. Proefrock B. Roedig 2002 Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer Clin Cancer Res 8 2116 2122
23. A.X. Zhu J.W. Clark D.P. Ryan J.A. Meyechardt P.C. Enzinger C.C. Earle 2007 Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer Cancer Chemother Pharmacol 59 285 293
24. J.A. Ajani F.C. Lee D.A. Singh D.G. Haller H.J. Lenz A.B. Benson III 2006 Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma J Clin Oncol 24 663 667
25. L. Kelland 2007 The resurgence of platinum-based cancer chemotherapy Cancer 7 573 584
26. C. Lourvet J.M. André E. Tigaud J.Y. Gamelin R. Douillard E. Brunet 2002 Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients J Clin Oncol 13 1469 1478
27. F. De Vita M. Orditura E. Matano R. Bianco C. Carlomagno S. Infusino 2005 A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients Br J Cancer 92 1644 1649
28. L. Cavanna F. Artioli C. Codignola A. Lazzaro A. Rizzi A. Gamboni 2006 Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC) Am J Clin Oncol 29 371 375
29. S.Y. Oh H.C. Kwon B.G. Seo S.H. Kin J.S. Kim H.J. Kim 2007 A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer Acta Oncol 46 336 341
30. J. Lee W.K. Kang J.M. Kwon S.Y. Oh H.R. Lee H.J. Kim 2007 Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma Ann Oncol 18 88 92
31. S. Al-Batran J. Hartmann S. Probst R. Hofheinz J. Stoehlmacher H. Schmalenberg 2006 A randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving firstline chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) Proc Am Soc Clin Oncol 2 4016
32. I. Park J. Lee M. Ryu H. Chang T. Kim S. Sym 2008 Phase I/II and pharmacokinetic study of combination chemotherapy with S-1 and oxaliplatin in patients with previously untreated metastatic or recurrent gastric cancer Proc Am Soc Clin Oncol 26 4557
33. N. Boku S. Yamamoto K. Shirao T. Doi W. Sawaki H. Koizumi 2007 Randomized phase III study of 5-fluorouracil (5-FU) alone versus combination of irinotecan and cisplatin (CP) versus S-1 alone in advanced gastric cancer (JCOG9912) Proc Am Soc Clin Oncol 25 4513
34. H. Narahara W. Koizumi T. Hara T. Takagane M. Akiya K. Takagi 2007 Randomized phase III study of S-1 alone versus S-1 + cisplatin in the treatment for advanced gastric cancer (the SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer Proc Am Soc Clin Oncol 25 4514